Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers-Reference-Cited by-同舟云学术

Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers

Published:2017-09-07 Issue:4 Volume:148 Page:308-313
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Gulbahce H Evin

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/148/4/308/20334541/aqx079.pdf

Reference14 articles.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;N Engl J Med,2001

2. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review;J Clin Oncol,2010

3. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer;FinHer Study Investigators;N Engl J Med,2006

4. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Herceptin Adjuvant (HERA) Trial Study Team;N Engl J Med,2005

5. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;N Engl J Med,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of 2018 ASCO/CAP guidelines on HER‐2 reporting categories of IHC and reflex FISH in breast cancer;The Breast Journal;2020-08-31

2. Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescentin-situhybridization and Immunohistochemistry: A meta-analysis with systematic review;International Journal of Molecular & Immuno Oncology;2020-01-21

3. The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines;Journal of Clinical Pathology;2019-11-15

4. American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory;American Journal of Clinical Pathology;2019-06-07

5. The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers;American Journal of Clinical Pathology;2019-01-21